4//SEC Filing
Corcoran Gavin 4
Accession 0001636050-21-000045
CIK 0001636050other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:52 PM ET
Size
6.1 KB
Accession
0001636050-21-000045
Insider Transaction Report
Form 4
Corcoran Gavin
EVP of R&D
Transactions
- Award
Stock Option (Right to Buy)
2021-04-15+244,300→ 244,300 totalExercise: $2.47Exp: 2031-04-14→ Common Stock (244,300 underlying)
Footnotes (1)
- [F1]The option vests over a period of three years with one-third of the shares of common stock underlying the option vesting on April 15, 2022 and the remainder vesting in 8 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of common stock. All shares of common stock underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan.
Documents
Issuer
Sio Gene Therapies Inc.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001745995
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:52 PM ET
- Size
- 6.1 KB